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ELIOT CORDAY, MD, FACe. STEPHEN R. CORDAY. MD. FACC
Los Angeles. California
The management of acute myocardial infarction in the
past 2S years has emerged from a state of masterful
inactivity to one of intensive care based on a new dis-
cipline of aggressive management. This has increased
the chances of survival of the victim of infarction and
could well be one of the major reasons for the decline
in mortality due to coronary heart disease in the United
States since 1968. Because resuscitative techniques must
be instituted within 4 minutes after the onset of cardiac
arrest, the attendant nurse had to learn the new emer-
gency lifesaving techniques and assume a crucial role as
a physician's assistant. The various stages in the evo-
lution of coronary care discipline began with car-
Myocardial infarction, the nation 's biggest killer 25 years
ago , retain s that position despite the revolutionary inno-
vations established in 1965 for its more aggressive man-
agement (I) . Before that historic date. this treacherous con-
dition was considered the natural end result of coronary
heart disease. which terminated life as though it were an
unavoidable act of fate. In fact. the medical profession of
1965 could provide little in the way of specific treatment to
influence the course of this disease . The standard treatment
of acute myocardial infarction was bed rest. the oxygen
mask and the judicious use of opiates to relieve pain . An-
ticoagulant therapy was adopted as standard practice to pre-
vent mural thrombus from ernbolizing. but there was con-
siderable debate about the actual benefit of this treatment
because clinical study had shown that it could have harmful
effects. The customary regimen of 4 to 6 weeks' bed rest
was also being challenged becau se of an increasing belief
that such inactivity caused phlebothrombosis of the periph-
eral circulation that could result in death from pulmonary
embolization .
Comprehensive investigations in the late I950s and early
1960s demonstrated the ominous hemodynamic conse-
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diopulmonary resuscitation and were followed by pace-
maker application, arrhythmia prophylaxis and inser-
tion of pulmonary venous flow-directed catheters and
arterial lines that permit monitoring and control of ven-
tricular filling pressures. Other developments in better
management of the failing heart have included methods
to salvage jeopardized myocardium, strategies for the
prevention of sudden death, the application of revas-
cularization techniques after acute coronary occlusion
and new noninvasive computerized technology to pro-
vide enhanced contrast images of cardiac perfusion that
can be directly integrated with measurement of function.
quences of arrhythmias and their abilit y to cause significant
ischemia of the target organ s, particularly of the myocar-
dium , when they were associated with a reduction in sys-
temic blood pressure (2-4). Therefore. administration of
vasopressors was advised for supportive treatment of ar-
rhythmias associated with hypotension and this often aborted
tachyarrhythmias (5).
Cardiogenic shock. which often supervenes after coronary
occlusion. was considered a serious emergency because it
was accompanied by an 80 to 90% mortality rate . It was
advocated that shock be treated by restoring diastolic cor-
onary filling pressures with blood transfusions or peripheral
vasoconstrictors. such as norepinephrine or metaraminol (6-
8). However. some authorities feared that these agents might
cau se a further increase in the work load for the already
failing heart (9) . If ventricular fibrillation or cardiac stand-
still occurred during acute myocardial infarction. it was
con sidered an untreatable terminal condition:
A New Era Emerges
Closed chest cardiac resuscitation, When electrical de-
fibrillation proved effecti ve for cardiac resuscitation in the
operating room (10-15). this maneuver was also recom-
mended for resuscitation of the victim of myocardial in-
farction . But at that time. succe ssful defibrillation neces-
sitated open chest massage and direct contact of the electrodes
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with the heart. By 1960 it was advocated that open chest
resuscitative techniques be replaced by the simple and more
practical closed chest resuscitation methods developed by
Kouwenhoven et al. (12-14). "Space age" bedside elec-
trocardiographic cathode ray monitor scopes with alarms for
high and low heart rates were developed to warn the nursing
staff of arrhythmias and of the onset of a cardiac arrest ( 11-
13) . Investigations on the fate of patients who had cardiac
arrest in the operating rooms of Los Angeles hospitals es-
tablished that if resuscitative measures were not instituted
within a 4 minute time limit (15). the heart might be re-
suscitated. but the brain. which could not withstand such
prolonged anoxia. was likely to become so severely dam-
aged that the victim would survive only as a helpless de-
cerebrate. It was repeatedly shown that in 60% of animals
and human beings who developed cardiac arrest. the arrest
occurred within the first hour after the acute myocardial
infarction. Therefore. it was urged that all patients suspected
of having an infarction be rushed to a facility where emer-
gency resuscitative measures were possible (16).
The coronary care unit. By 1965. effective closed chest
resuscitation and safe electrical countershock and defibril-
lation techniques began to be accepted by cardiologists (I I-
17). Although approximately 14 coronary care units had
been established. across the continent. most cardiologists
questioned the clinical benefits of such units. Many believed
that the aggressive management of coronary occlusion was
an expensive exercise in futility. but a few investigators
reported dramatic lifesaving results. A Bethesda Conference
of coronary care unit directors convened at the American
College of Cardiology headquarters in December 1965 to
determine if the newly proposed aggressive management in
an intensive coronary care unit could ever be of practical
benefit (I). During the deliberations. participants soon re-
alized that the coronary care directors at three centers-
Hughes Day in Kansas City. Lawrence Meltzer in Phila-
delphia and Paul Unger in Miami-were reporting salvage
of a significant number of victims of cardiac arrest. They
were able to accomplish this feat because their nurses were
in constant attendance in the coronary care unit and had
been trained to read the abnormal heart rhythms that could
document onset of cardiac arrest on the fast-moving cathode
ray electrocardiographic monitor. These nurses had also
been trained to perform immediate cardiac resuscitation us-
ing closed chest ventilation and electrical defibrillation (I).
By allowing the attending nurses to defibrillate the patient' s
heart even in the absence of a physician. many patients
could be saved. The Conference concluded that because of
the narrow 4 minute time limit. the nursing staff must be
trained to perform cardiopulmonary resuscitation and to ad-
minister appropriate prophylactic pharmacologic interven-
tions, such as antiarrhythmic drugs. to prevent cardiac ar-
rest. The Conference report (I) recommended that the U.S.
Congress appropriate funds for training the coronary care
nursing staff in their new responsibilities. By March 1966.
the president of the American College of Cardiology. ac-
companied by the executive director. presented SenatorLister
Hill with the Bethesda Conference Committee's recom-
mendation for 3 years' funding of a nationwide training
program for nurses. The senator agreed with the report and
within 5 days arranged to have the necessary appropriation
of $27 million attached to a railroad bill that was subse-
quently signed by President Lyndon Johnson. This is really
a most appropriate use of the term " railroading."
Under the strong leadership of Samuel Fox III. head of
the Heart Disease Control Section of the U. S. Public Health
Service. training programs based on new aggressive prin-
ciples for treating the victim of myocardial infarction were
rapidly instituted across the nation and by 1968. some 6.000
of the larger hospitals in the country were prepared to ad-
minister immediate resuscitation and defibrillation in the
newly established coronary care units. New state laws had
to be instituted to permit nursing staffs to assume duties that
were previously performed only by physicians. Soon other
aggressive programs. including the judicious use of pace-
makers and antiarrhythmic drugs. were adopted to prevent
further complications from arrhythmias that might otherwise
herald the onset of cardiac arrest (18).
Benefits derived from coronary care units. The cor-
onary care programs of the American College of Cardiology
and the American Heart Association were accepted with
unanticipated vigor because of widespread publicity that the
lives of thousands of people with a heart ' 'too good to die"
were being saved. Within a few years. most states had
passed laws requiring practitioners to pass a cardiopulmon-
ary resuscitation examination before they could renew their
annual staff privileges. The conferees of the Bethesda Con-
ference estimated that 45,000 lives per year would be saved
with the adoption of the new aggressive methods in the
coronary care unit (I). However, the health planners did
not set up randomized studies to learn exactly how many
lives could be saved by the coronary care units. In recent
years, some attempts to determine the survival rates have
yielded statistics that seem to refute any possible benefits
derived from the coronary care unit concept. However, these
efforts have been discounted by some because the numbers
were too small and the subgroups were not appropriately
organized to provide statistically meaningful results. The
cardiac care units in the studies were considered substandard
in organization and quality. and many patients were trans-
ferred in and out of the coronary care unit because their risk
of death changed after initial randomization. It now seems
to be too late to perform an appropriate randomized study
because there is such great faith in the coronary care unit
and the aggressive management entailed has become stan-
dard practice. To those who doubt the efficacy of the cor-
onary care unit, we suggest they review the survival statistics
of the thousands who were resuscitated in their local facil-
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ities to see that without such resuscitative maneuvers, sur-
vival of victims of cardiac arrest would be rare.
A More Appropriate Research Program
Initiated to Improve Basic Knowledge About
Acute Myocardial Infarction
Stimulated by these dramatic breakthroughs, Robert Grant,
Director of the National Heart Institute, noted that the re-
search budget for myocardial infarction, the nation's leading
cause of death, received only a meager 1% of the total
research allotment made by the National Institutes of Health.
After raising a congressional appropriation of about $15
million a year, with the help of Michael Defsakey, to support
more intensive studies in basic research and clinical appli-
cations for the management of acute myocardial infarction,
Grant died suddenly, the victim of a fatal heart attack. But
the momentum created by his endeavor has continued to
this day and made many other dramatic breakthroughs
possible.
Myocardial infarction research units. The program
eventually blossomed into nine productive myocardial in-
farction research units across the nation, under the direction
of Peter Frommer, MD, of the National Heart Institute.
Many new clinical concepts emanated from these myo-
cardial infarction research units. One of the most important
advances attributed to the program was the development of
the Swan-Ganz pulmonary artery flotation catheter, which
enables continuous hemodynamic monitoring of cardiac out-
put and regulation of fluids and drugs to provide most ap-
propriate left ventricular filling pressures (18). Intraarterial
pressure lines were adapted to monitor systemic vascular
resistance for better regulation of coronary filling pressures
and the afterload of the failing heart by application of vaso-
dilators, vasopressors or alpha- or beta-receptor blocking
agents, or both. This ingenious online monitoring of hemo-
dynamic function has saved many patients with complica-
tions of pump failure (18,19). The hemodynamic monitor-
ing, now a standard form of therapy, was an effective aid
in the management of interventions such as volume loading,
intraaortic balloon assistance, afterload and preload reduc-
tions or administration of selective vasopressors. Thus, the
occurrence of, and mortality from, cardiogenic shock is now
markedly diminished (19).
Preservation of Jeopardized
Ischemic Myocardium
Pharmacologic interventions. Starting in 1968, interest
was renewed in methods that might preserve jeopardized
ischemic myocardium (6,20,21). It was thought that such
preservation would reduce infarct size and prevent subse-
quent chronic cardiac decompensation, troublesome ar-
rhythmias and sudden death. Some pharmaceutical agents
proposed for salvaging jeopardized myocardium were ni-
troglycerin, nitroprusside, hypertonic mannitol, propranolol
hydrochloride, hyaluronidase, prednisolone, allopurinal and
heparin. Although these investigations stimulated great in-
terest, by 1976 the published data consisted of many con-
flicting claims and the status of the concept of myocardial
salvage had to be reevaluated (21-24). Actually, each of
the opinions seemed to be correct for the investigator's
particular protocol design, but the contradictory results seemed
to emanate from the differences in study models (dogs versus
human beings) and in the mode and schedules of admin-
istration of the pharmaceutical agent or physical interven-
tions. It appeared that the mode of administration and timing
of an intervention must be uniform. In retrospect it appears
that if more than 3 hours elapsed between the onset of the
coronary occlusion and the intervention, the ischemic myo-
cardium would have been so irreversibly damaged that any
treatment stood little chance of salvaging significant amounts
of myocardium (22-24).
Reperfusion phenomenon. In addition, some investi-
gators revealed an unusual phenomenon that occurred in
about 16% of animals undergoing reperfusion within 4 hours
of occlusion (24). This phenomenon was associated with
serious arrhythmias and a metabolic disturbance of the myo-
cardium that included loss of potassium and anaerobic lactic
acid production. At necropsy, the myocardium was char-
acterized by hemorrhage, interstitial and intracellular edema
of the ischemic area and fragmentation of the myofibrils. It
was believed that such swelling in the ischemic area pre-
vented blood from reentering the region, causing a "no
reflew" phenomenon (24). It is evident that the earlier the
reperfusion is started-by coronary bypass surgery, throm-
bolysis, synchronized retroperfusion or other general sup-
portive hemodynamic measures (such as reduction in after-
load or improved preload)-the better the possibility of
preventing the reperfusion phenomenon (19).
Sudden Cardiac Death
New concepts have emerged since 1966 concerning sudden
cardiac death, a syndrome that claims between 300,000 to
400,000 lives each year in the United States (25-29). Ab-
normal rhythms and atrioventricular conduction defects that
might warn patients that they are in danger include high
grade premature ventricular beats, ventricular tachyarrhyth-
mias or bradycardias due to ischemic heart disease. Unfor-
tunately, because of their ischemic origin, these arrhythmias
are resistant to prophylactic therapy. The risk factors as-
sociated with sudden cardiac death appear to be those that
indicate already well established coronary disease and in-
clude previous myocardial infarction, abnormal electrocar-
diograms or ventricular arrhythmias, but not the usual risk
factors of arteriosclerosis as we now understand them (18,
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19,25-29). There is a high risk of sudden cardiac death in
patients who have sustained a myocardial infarction during
the previous year, and particularly in those who have evi-
dence of significant ectopic arrhythmias in the 2nd and 3rd
weeks after acute myocardial infarction. Our main thrust
must be to provide practical techniques to identify the can-
didate for sudden cardiac death and to provide more effective
prophylactic agents that might prevent the catastrophe (19).
New Diagnostic Technology of Acute and
Chronic Ischemic Process
In the past decade. the limits of accuracy of both new and
established techniques to diagnose the acute and chronic
ischemic process, including electrocardiographic stress tests.
angiography and enzymology, have been placed in their
proper perspective (19). For instance, selective coronary
angiography and ventriculography have been improved in
the past 25 years to localize and measure the degree of
obstruction within the native coronary circulation as well
as abnormal ventricular wall motion. chamber volume and
ejection fraction associated with myocardial ischemia (J 9).
But diagnostic decisions must be based on the assessed
degree of coronary artery narrowing, and these assessments
are not clear cut and are often subject to large margins of
error in quantitation (19). Cost-effective technology must
be developed to improve the angiographic technique to pro-
vide even better images for quantitative measurements with
less radiation and less financial expense to permit safer.
more economic and more certain selection of the candidate
for coronary bypass surgery, percutaneous coronary angio-
plasty or thrombolysis. Many clinicians recommend early
coronary angiography for patients surviving myocardial in-
farction, but most believe that this expensive process should
be reserved for patients with continuing symptoms.
New Image Technology
Recent advances have been made in imaging pathophys-
iologic phenomena of the beating heart with nuclear scin-
tigraphy, two-dimensional echocardiography and digital
subtraction angiography. Each of these techniques can por-
tray normal or abnormal cardiac function, such as wall mo-
tion abnormalities that change from a normal inward con-
tractile motion toward the center of the left ventricle to a
loss of such contractility (akinesia) or ballooning outward
(dyskinesia). They also can portray ventricular wall thick-
ening during systole and reveal thinning of the wall in
ischemic situations. Chamber volumes in diastole can be
seen to increase within a few heartbeats after coronary oc-
clusion, and ejection fraction diminishes. In addition. the
nuclear tracer thallium will accumulate in normally perfused
regions and its absence can be utilized to portray a region
of ischemia or infarction.
Radionuclide technology. Although attempts had been
made to apply radioisotopic methods to cardiology since
1947 (6.30-36), advances in this technology were not pos-
sible until improved scintigraphic techniques were devel-
oped to image the low concentration of nuclear material
passing through the cardiac chambers or deposited in the
myocardium. Computer applications and background sub-
traction in the last decade made significant image enhance-
ment possible (36). Nuclear methods can now be applied
for the management of patients with myocardial infarction
to image the extent of an acute or chronic ischemic process,
detect transient ischemic events after stress and correlate
these findings with measurements of regional wall motion
abnormalities, cardiac volume and ejection fraction.
Two-dimensional echocardiography. In the past 6 years,
two-dimensional echocardiographic techniques were devel-
oped to quantitate alterations in cardiac function (37-40).
Alterations of cardiac function ascribed to ischemia include
regional and global alterations in chamber volume. wall
motion and wall thickening. Most often these changes occur
within the first few heartbeats after coronary occlusion. On
early reperfusion all functional changes may be reversed.
As the ischemic areas extend, further impairment of function
occurs. Measurements of function with two-dimensional
echocardiography that portray ischemia include those of
regional wall kinetics (akinesia to dyskinesia). reduced frac-
tional area of change. increase in right and left ventricular
and atrial chamber areas and volumes. normal wall thick-
ening that occurs during systole and changes toward thin-
ning. ventricular aneurysm formation and papillary muscle
dysfunction with prolapse of the mitral or tricuspid valve.
Excellent images can now provide complete delineation of
endocardial and epicardial borders for quantitating ejection
fraction indexes, regional areas of change and chamber vol-
umes. Computerization of cardiac endocardial and epicar-
dial outlines and applied two-dimensional echocardio-
graphic studies now provide data for evaluating changing
quantitative measurements of ischemic dysfunction and
physical and pharmaceutical interventions (38,39). Selected
portions of the fast-moving phasic echocardiographic im-
ages processed by the computer can now be displayed side
by side for serial comparison and quantitated automatically
by the computer to depict the degree of progressive ischemic
dysfunction or the benefits of interventions during the man-
agement of the patient in the coronary care unit (37). Con-
trast injection techniques developed by our group (41) per-
mit identification of regions of ischemia for more accurate
diagnosis of developing anatomic lesions or reperfusion phe-
nomena. Further. two-dimensional echocardiographic bi-
cycle stress tests have been perfected to provide diagnostic
images of abnormal ischemic wall motion and changes in
chamber volume while the patient is exercising (40).
It is now evident that the clinician can confidently choose
from a battery of electrocardiographic. ultrasonic and nu-
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clear methods that complement and supplement the knowl-
edge of a single test to detect the earliest abnormalities of
ischemic dysfunction when a myocardial infarction occurs
(32-42).
Unsolved Problems of Acute
Myocardial Infarction
Existing controversies continue regarding fundamental con-
cepts in causation of acute ischemia leading to infarction
(19). Some workers believe that most cases of infarction
result from coronary angiospasm. but others observe that
this is a rare occurrence (43). Dynamic pathophysiologic
concepts must explain when the irreversible ischemic changes
occur. Are clinical infarct size measurements accurate? Is
there an ischemic' 'twilight zone" around a central area of
necrosis that can be reversed by delayed interventions? What
is the significance of the collateral circulation in control of
infarct size and how can it be implemented? Emerging con-
cepts that are associated with ischemic syndromes must
receive more attention, such as the excessive metabolic de-
mands in hypertrophic cardiomyopathies and the relation of
acute myocardial ischemia to the prolapsing mitral valve
syndrome. The attending cardiologist needs to know if it is
possible to reduce the obstructive arteriosclerotic lesion by
control of risk factors after myocardial infarction occurs
(19). However, there is considerable disagreement regarding
the possible benefits of risk factor interventions to prevent
atherosclerosis (44,45).
Revascularization of the Acute Ischemic
Myocardium
New developments in the attempt to revascularize ischemic
myocardium immediately after coronary occlusion are of
great interest to the cardiologist (46,47). These interventions
include: I) immediate coronary bypass; 2) systemic intra-
venous administration, intravenous coronary sinus retro-
perfusion and antegrade coronary artery flushing of strep-
tokinase to dissolve an occlusive thrombus (44,45); 3)
percutaneous transluminal coronary angioplasty (PTCA) of
a narrowed coronary artery (48); and 4) the use of syn-
chronized retroperfusion of arterial blood that is cooled be-
low body temperature and pumped into the heart by way of
the coronary sinus (47). The latter two interventions are of
great interest but must still be considered to be of an ex-
perimental nature. It is obvious from previous studies that
these interventions must be applied as early as possible, at
least within 3 to 4 hours after occlusion. before the heart
damage becomes irreversible. These experimental methods
will be discussed in more detail in early issues of this Journal
(49).
Conclusions
Stages ofNeH' Aggressive Interventions for the
Management of Acute Myocardial Infarction
The stages of the rapid developments in the modern man-
agement of myocardial infarction can be summarized chro-
nologically:
Stage 1. Continuous electrocardiographic monitoring of
the acute coronary patient
Stage 2. Authorization and training of attending nurses
to defibrillate the heart of patients
Stage 3. Prophylactic and continuous intravenous drip
treatment of the irritable heart
Stage 4. Electrical pacemakers for treatment of acute
heart block and extreme bradycardia
Stage 5. Pulmonary artery flow-directed catheters for
estimating left ventricular filling pressure
Stage 6. Treatment of the failing heart by control mea-
sures affecting afterload and preload
Stage 7. Interventions to salvage jeopardized ischemic
myocardium. including revascularization with throm-
bolytic agents and coronary sinus retroperfusion
Stage 8. Coronary bypass surgery for: a) acute coronary
occlusion, b) impending infarction, c) high risk le-
sions, d) extending infarction
Stage 9. New noninvasive imaging technology
Why the Reduction in Coronary Disease Mortality?
Many wonder about the probable reasons for the decreased
mortality of coronary heart disease since 1966 despite an
unchanged incidence of acute myocardial infarction (50).
Many factors appear to be responsible: I) public awareness
of the acute coronary symptoms and the need to seek emer-
gency skilled treatment; 2) practical resuscitation within the
4 minute limit for emergency treatment of cardiac arrest; 3)
aggressive management of the acute coronary victim in the
coronary care unit; 4) prophylactic treatment of ominous
arrhythmias; 5) aggressive management of pacemaker prob-
lems; 6) acceptance of beta-receptor blocking agents and
nitrates for treatment of angina pectoris; 7) coronary bypass
surgery for up to 150.000 potential victims of coronary
disease in the United States each year; 8) freedom from
catastrophic epidemics of influenza in recent years which
has improved longevity of all patients; 9) alterations in the
International Classification of Diseases. which changed sta-
tistical methods for providing death classification each year;
and 10) control of risk factors such as hypertension, tobacco
smoking (43) and perhaps even serum lipids.
At present each cardiologist has his or her own private
beliefs on how the battle is being won, and we must await
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the renewed scientific analy sis to determine which of the
advance s has contributed most to the reduced mortal ity.
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